These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

884 related articles for article (PubMed ID: 28329060)

  • 1. First series of left ventricular assist device exchanges to HeartMate 3.
    Hanke JS; Rojas SV; Dogan G; Feldmann C; Beckmann E; Deniz E; Wiegmann B; Michaelis JE; Napp LC; Berliner D; Shrestha M; Bauersachs J; Haverich A; Schmitto JD
    Eur J Cardiothorac Surg; 2017 May; 51(5):887-892. PubMed ID: 28329060
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Three-year follow-up after less-invasive left ventricular assist device exchange to HeartMate 3™.
    Hanke JS; Mariani S; Merzah AS; Bounader K; Li T; Haverich A; Schmitto JD; Dogan G
    J Cardiovasc Surg (Torino); 2021 Dec; 62(6):646-651. PubMed ID: 34057162
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of left ventricular assist device (HeartMate II): a Singapore experience.
    Lim CP; Sivathasan C; Tan TE; Lim CH; Kerk KL; Sim DK
    Artif Organs; 2014 Jul; 38(7):543-8. PubMed ID: 24392937
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design changes in continuous-flow left ventricular assist devices and life-threatening pump malfunctions.
    Soltani S; Kaufmann F; Vierecke J; Kretzschmar A; Hennig E; Stein J; Hetzer R; Krabatsch T; Potapov EV
    Eur J Cardiothorac Surg; 2015 Jun; 47(6):984-9. PubMed ID: 25209626
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Left Ventricular Assist Device Malfunctions: It Is More Than Just the Pump.
    Kormos RL; McCall M; Althouse A; Lagazzi L; Schaub R; Kormos MA; Zaldonis JA; Sciortino C; Lockard K; Kuntz N; Dunn E; Teuteberg JJ
    Circulation; 2017 Oct; 136(18):1714-1725. PubMed ID: 28674109
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Device exchange after primary left ventricular assist device implantation: indications and outcomes.
    Stulak JM; Cowger J; Haft JW; Romano MA; Aaronson KD; Pagani FD
    Ann Thorac Surg; 2013 Apr; 95(4):1262-7; discussion 1267-8. PubMed ID: 23063192
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical Experience of HeartMate II to HeartWare Left Ventricular Assist Device Exchange: A Multicenter Experience.
    Agarwal R; Kyvernitakis A; Soleimani B; Milano CA; Davis RP; Kennedy JL; Yarboro L; Benza RL; Moraca RJ; Bailey SH
    Ann Thorac Surg; 2019 Oct; 108(4):1178-1182. PubMed ID: 31059685
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interagency Registry for Mechanically Assisted Circulatory Support (INTERMACS) analysis of pump thrombosis in the HeartMate II left ventricular assist device.
    Kirklin JK; Naftel DC; Kormos RL; Pagani FD; Myers SL; Stevenson LW; Acker MA; Goldstein DL; Silvestry SC; Milano CA; Baldwin JT; Pinney S; Eduardo Rame J; Miller MA
    J Heart Lung Transplant; 2014 Jan; 33(1):12-22. PubMed ID: 24418730
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Device exchange from Heartmate II to HeartWare HVAD.
    Beaupre RA; Alnajar A; Sugiura T; Chou B; Lamba HK; Kurihara C; Kawabori M; Critsinelis AC; Santiago A; Morgan JA
    J Card Surg; 2019 Nov; 34(11):1204-1207. PubMed ID: 31478230
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Viennese approach to minimize the invasiveness of ventricular assist device implantation†.
    Haberl T; Riebandt J; Mahr S; Laufer G; Rajek A; Schima H; Zimpfer D
    Eur J Cardiothorac Surg; 2014 Dec; 46(6):991-6; discussion 996. PubMed ID: 24623170
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early outcomes with durable left ventricular assist device replacement using the HeartMate 3.
    Barac YD; Wojnarski CM; Junpaparp P; Jawitz OK; Billard H; Daneshmand MA; Agrawal R; Devore A; Patel CB; Schroder JN; Milano CA
    J Thorac Cardiovasc Surg; 2020 Jul; 160(1):132-139.e1. PubMed ID: 31740114
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of device thrombus in the HeartWare HVAD: Success and outcomes depend significantly on the initial treatment strategy.
    Stulak JM; Dunlay SM; Sharma S; Haglund NA; Davis MB; Cowger J; Shah P; Masood F; Aaronson KD; Pagani FD; Maltais S
    J Heart Lung Transplant; 2015 Dec; 34(12):1535-41. PubMed ID: 26681123
    [TBL] [Abstract][Full Text] [Related]  

  • 13. One-year outcomes with the HeartMate 3 left ventricular assist device.
    Hanke JS; Dogan G; Zoch A; Ricklefs M; Wert L; Feldmann C; Bara C; Shrestha M; Tillmanns J; Kempf T; Bauersachs J; Haverich A; Schmitto JD
    J Thorac Cardiovasc Surg; 2018 Aug; 156(2):662-669. PubMed ID: 29525258
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outcomes after implantation of 139 full-support continuous-flow left ventricular assist devices as a bridge to transplantation.
    Sabashnikov A; Mohite PN; Weymann A; Patil NP; Hedger M; Sáez DG; Zych B; Wahlers T; Wippermann J; De Robertis F; Bahrami T; Amrani M; Simon AR; Popov AF
    Eur J Cardiothorac Surg; 2014 Nov; 46(5):e59-66. PubMed ID: 25180072
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Left ventricular assist device exchange for the treatment of HeartMate II pump thrombosis.
    Hanke JS; Dogan G; Wert L; Ricklefs M; Heimeshoff J; Chatterjee A; Feldmann C; Haverich A; Schmitto JD
    J Thorac Dis; 2018 Jun; 10(Suppl 15):S1728-S1736. PubMed ID: 30034845
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Results of the post-U.S. Food and Drug Administration-approval study with a continuous flow left ventricular assist device as a bridge to heart transplantation: a prospective study using the INTERMACS (Interagency Registry for Mechanically Assisted Circulatory Support).
    Starling RC; Naka Y; Boyle AJ; Gonzalez-Stawinski G; John R; Jorde U; Russell SD; Conte JV; Aaronson KD; McGee EC; Cotts WG; DeNofrio D; Pham DT; Farrar DJ; Pagani FD
    J Am Coll Cardiol; 2011 May; 57(19):1890-8. PubMed ID: 21545946
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Durability of left ventricular assist devices: Interagency Registry for Mechanically Assisted Circulatory Support (INTERMACS) 2006 to 2011.
    Holman WL; Naftel DC; Eckert CE; Kormos RL; Goldstein DJ; Kirklin JK
    J Thorac Cardiovasc Surg; 2013 Aug; 146(2):437-41.e1. PubMed ID: 23490245
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improved survival and decreasing incidence of adverse events with the HeartMate II left ventricular assist device as bridge-to-transplant therapy.
    John R; Kamdar F; Liao K; Colvin-Adams M; Boyle A; Joyce L
    Ann Thorac Surg; 2008 Oct; 86(4):1227-34; discussion 1234-5. PubMed ID: 18805167
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical experience with sternotomy versus subcostal approach for exchange of the HeartMate XVE to the HeartMate II ventricular assist device.
    Gregoric ID; Bruckner BA; Jacob L; Kar B; Cohn WE; La Francesca S; Frazier OH
    Ann Thorac Surg; 2008 May; 85(5):1646-9. PubMed ID: 18442556
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is it Possible to Implant HeartMate 3 Less Invasively? New Pump, New Approach.
    Kocabeyoglu SS; Kervan U; Sert DE; Unal EU; Demirkan B; Guray Y; Aygun E; Beyazal OF; Karahan M; Pac M
    Artif Organs; 2018 Dec; 42(12):1132-1138. PubMed ID: 30393885
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 45.